Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| FKA-H5122 | Human | Human FKBP12 / FKBP1A Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Tacrolimus Hydrate | LCP-Tacro; FR-900506; L-679934; FK-506MR; FK-506E; FK-506; MR-4; RTU-007 | Approved | Astellas Pharma Inc | Protopy, Graceptor (as hydrate), Protopic, Prograf (as hydrate), Hecoria (as hydrate), Hexal, Envarsus XR, Talymus, 普乐可复, Advagraf, Envarsus, Modigraf, Astagraf XL, TacroBell | United States | Rejection in heart transplantation; Rejection of liver transplantation; Rejection of renal transplantation | Astellas Pharma Us Inc | 1994-04-08 | Keratoconjunctivitis; Dry Eye Syndromes; Conjunctivitis; Psoriasis; Pulmonary Arterial Hypertension; Amputation, Traumatic; Burns; Asthma; Surgical Wound Infection; Colitis, Ulcerative; Rejection in heart transplantation; Infertility, Female; Lupus Nephritis; Hamman-Rich Syndrome; Nephrotic Syndrome; Renal Insufficiency, Chronic; Wounds and Injuries; Vitiligo; Dermatitis, Atopic; Peripheral Nerve Injuries; Ocular inflammation; Edema; Encephalitis; Crohn Disease; Glomerulonephritis, IGA; Rejection of renal transplantation; Reperfusion Injury; Myasthenia Gravis; Medication Adherence; Keratoconjunctivitis Sicca; Genital Diseases, Male; Bone marrow transplant rejection; Liver Failure; Rejection of lung transplantation; Rejection of liver transplantation; Renal Insufficiency; Polymyositis; Primary Graft Dysfunction; Rejection of pancreatic transplantation; Keratoplasty rejection; Dermatomyositis; Kidney Diseases; Lupus Erythematosus, Cutaneous; Graft vs Host Disease; Arthritis, Rheumatoid; Lung Diseases, Intersti | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| MAM-1003-1 | MAM-1003-1 | Phase 2 Clinical | Marinomed Biotech AG | Rhinitis, Allergic; Conjunctivitis, Allergic | Details |
| Plerixafor/Tacrolimus Hydrate | AMD3100+FK506; MRG-001(MedRegen) | Phase 2 Clinical | MedRegen LLC | Motor Neuron Disease; Cytokine Release Syndrome; Hepatitis, Alcoholic; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Abdominal Injuries; Wounds and Injuries; Respiratory Insufficiency; Amyotrophic Lateral Sclerosis | Details |
| Rimiducid | AP-1903 | Phase 2 Clinical | Ariad Pharmaceuticals Inc, Bellicum Pharmaceuticals Inc | Lymphoma, Non-Hodgkin; Blastic Plasmacytoid Dendritic Cell Neoplasm; Anemia, Aplastic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Osteopetrosis; Metabolic Diseases; Osteosarcoma; Sarcoma; Neuroblastoma; Prostatic Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Leukemia, Myeloid, Acute; Cytopenia; Lymphoma; Lymphohistiocytosis, Hemophagocytic; Congenital Bone Marrow Failure Syndromes; Melanoma; Leukemia, Biphenotypic, Acute; Anemia, Sickle Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Thalassemia; Hematologic Neoplasms; Primary Immunodeficiency Diseases; Solid tumours; Neoplasm, Residual; Bone Marrow Neoplasms; Leukemia; Leukemia, Myelogenous, Chronic; Lymphatic Diseases; Immunoproliferative Disorders; Leukemia, Lymphoid; Lymphoma, B-Cell; Anemia, Diamond-Blackfan; Myeloproliferative Disorders; Myelodysplastic Syndromes; Graft vs Host Disease; Hemoglobinopathies; Leukemia, Myelomonocytic, Chronic; Fanconi Anemia; Uveal melanoma; Mult | Details |
This web search service is supported by Google Inc.
A-Z
